The next-generation RET inhibitor TPX-0046 is active in drug-resistant and naïve RET-driven cancer models Meeting Abstract
| Authors: | Drilon, A. E.; Zhai, D. Y.; Rogers, E.; Deng, W.; Zhang, X.; Ung, J.; Lee, D.; Rodon, L.; Graber, A.; Zimmerman, Z. F.; Murray, B. W.; Subbiah, V. |
| Abstract Title: | The next-generation RET inhibitor TPX-0046 is active in drug-resistant and naïve RET-driven cancer models |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 193s |
| Language: | English |
| ACCESSION: | WOS:000560368301506 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.3616 |
| Notes: | Meeting Abstract: 3616 -- Source: Wos |
